Clinical trial
The Effectiveness of ASA, SORT and Sarcopenia Indices in Estimating Mortality and Morbidity in Gastrointestinal Tumour Surgery
NCT05583292 is registered in ClinicalTrials.gov with Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness of ASA, SORT and Sarcopenia Indices in Estimating Mortality and Morbidity in Gastrointestinal Tumour Surgery
- Lead sponsor
- Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 11, 2023
- Completion date
- August 15, 2023
- Enrollment
- 111 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal tumours